fluorodeoxyglucose f18 has been researched along with Supranuclear Palsy, Progressive in 57 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (5.26) | 18.7374 |
1990's | 6 (10.53) | 18.2507 |
2000's | 13 (22.81) | 29.6817 |
2010's | 26 (45.61) | 24.3611 |
2020's | 9 (15.79) | 2.80 |
Authors | Studies |
---|---|
Eidelberg, D; Ležaić, L; Perovnik, M; Rebec, E; Rus, T; Studen, A; Tang, CC; Tomše, P; Trošt, M | 1 |
Ahlskog, JE; Ali, F; Botha, H; Carlos, AF; Clark, HM; Coon, EA; Dickson, DW; Josephs, KA; Koga, S; Lowe, V; Pham, NTT; Sekiya, H; Trejo-Lopez, JA; Whitwell, JL | 1 |
Azulay, JP; Ceccaldi, M; Felician, O; Grimaldi, S; Guedj, E; Koric, L; Labouré, J; Pin, G | 1 |
Apostolova, I; Barthel, H; Berding, G; Brendel, M; Buchert, R; Buhmann, C; Dierks, A; Eidelberg, D; Höglinger, G; Huppertz, HJ; Katzdobler, S; Klietz, M; Levin, J; Mahmoudi, N; Rinscheid, A; Rogozinski, S; Rumpf, JJ; Sabri, O; Schneider, C; Spetsieris, PG; Stöcklein, S; Wattjes, MP; Wegner, F | 1 |
Blesa, R; Camacho, V; Fernández León, A; Lleó, A; López-Mora, DA | 1 |
Eidelberg, D; Grmek, M; Jensterle, L; Pirtošek, Z; Rus, T; Tang, C; Tomše, P; Trošt, M | 1 |
Gao, S; Li, X; Zhang, B; Zhao, P | 1 |
Berti, V; Cappa, SF; Catricalà, E; Conca, F; Esposito, V; Filippi, M; Gasparri, C; Iannaccone, S; Magnani, G; Perani, D; Polito, C; Presotto, L; Pupi, A; Sala, A; Sorbi, S | 1 |
Ali, F; Botha, H; Clark, HM; Duffy, JR; Josephs, KA; Lowe, VJ; Machulda, MM; Seckin, ZI; Strand, EA; Thu Pham, NT; Utianski, RL; Whitwell, JL | 1 |
Artiko, V; Brajkovic, L; Castiglioni, I; Gallivanone, F; Jecmenica-Lukic, M; Jesic, A; Kostic, V; Odalovic, S; Radovic, B; Sobic-Saranovic, D; Stefanova, E; Stojiljkovic, M; Trajkovic, G | 1 |
Eidelberg, D; Ge, J; Guan, Y; Ma, Y; Peng, S; Wang, J; Wu, J; Wu, P; Zhang, H; Zuo, C | 1 |
De Jong, BM; Dierckx, RA; Leenders, KL; Mudali, D; Renken, RJ; Roerdink, JB; Teune, LK | 1 |
Botha, H; Dickson, DW; Josephs, KA; Lowe, V; Whitwell, JL; Zalewski, N | 1 |
Amtage, F; Glauche, V; Hellwig, B; Hellwig, S; Kreft, A; Meyer, PT; Rijntjes, M; Spehl, T; Tüscher, O; Weber, WA; Weiller, C; Winkler, C | 1 |
Amtage, F; Buchert, R; Guschlbauer, B; Hellwig, S; Meyer, PT; Niesen, WD; Reinhard, M; Tüscher, O; Weiller, C | 1 |
Amtage, F; Hellwig, S; Kreft, A; Maurer, C; Meyer, PT; Rijntjes, M; Tüscher, O; Weiller, C; Winkler, C | 1 |
Duffy, JR; Gunter, JL; Jack, CR; Josephs, KA; Lowe, VJ; Machulda, MM; Reid, RI; Schwarz, CG; Senjem, ML; Spychalla, AJ; Strand, EA; Whitwell, JL | 1 |
Allen, PJ; Amtage, F; Eidelberg, D; Feigin, A; Hanspal, E; Heinen, L; Hellwig, S; Leenders, KL; Meyer, PT; Niethammer, M; Poston, KL; Tang, CC; Vonsattel, JP | 1 |
Berlot, R; Kojović, M | 1 |
Amaral, LL; Barsottini, OG; Belezia, AB; Marussi, VH; Oliveira, AS; Pedroso, JL; Yared, J | 1 |
Amtage, F; Buchert, R; Frings, L; Hellwig, S; Meyer, PT; Rijntjes, M; Spehl, TS; Tüscher, O; Vach, W; Weber, WA; Weiller, C | 1 |
Atkinson, R; Brooks, DJ; Edison, P; Fan, Z; Femminella, GD; Ninan, S | 1 |
Arighi, A; Bertram, K; Cioffi, SM; Colosimo, C; Fenoglio, C; Formica, A; Galimberti, D; Scarpini, E | 1 |
Ahn, JW; Choi, KU; Huh, GY; Jung, DS; Jung, NY; Kim, BK; Kim, EJ; Kim, SJ; Lee, JH; Lee, MJ; Lee, YM; Seeley, WW; Shin, JH; Shin, MJ; Sung, S | 1 |
Englund, E; Hansson, O; Honer, M; Nilsson, CF; Schöll, M; Smith, R | 1 |
Aigbirhio, FI; Allinson, KS; Arnold, R; Bevan-Jones, WR; Borchert, RJ; Cope, TE; Fryer, TD; Hong, YT; Jones, PS; Mak, E; O'Brien, JT; Passamonti, L; Rowe, JB; Sami, S; Su, L; Surendranathan, A; Vázquez Rodríguez, P; Williamson, D | 1 |
Chung, SJ; Im, KC; Kim, JS; Kim, MJ; Lee, JH; Lee, MC; Oh, SJ; Park, HK | 1 |
Castelnovo, G; Collombier, L; Labauge, P; Renard, D | 1 |
Go, SM; Kim, EJ; Na, DL; Roh, JH; Seo, SW; Suh, MK | 1 |
Bartenstein, P; Brandt, T; Deutschenbaur, L; Dieterich, M; Jahn, K; Krafczyk, S; la Fougère, C; Linn, J; Lorenzl, S; Rominger, A; Strupp, M; Xiong, G; Zwergal, A | 1 |
Lewitt, PA; Sidiropoulos, C | 1 |
Gao, S; Zhang, B; Zhao, P | 1 |
Bauer, S; Berg, D; Dietzel, E; Liepelt-Scarfone, I; Liscic, RM; Maetzler, W; Reimold, M; Srulijes, K | 1 |
Amtage, F; Buchert, R; Hellwig, B; Hellwig, S; Kreft, A; Meyer, PT; Rijntjes, M; Spehl, TS; Tüscher, O; Vach, W; Weber, WA; Weiller, C; Winkler, C; Winz, OH | 1 |
Guo, XJ; Li, DC; Ma, AJ; Pan, XD; Zhang, BS | 1 |
Bartenstein, P; Brandt, T; Deutschenbaur, L; Dieterich, M; Jahn, K; la Fougère, C; Linn, J; Lorenzl, S; Rominger, A; Schöberl, F; Strupp, M; Xiong, G; Zwergal, A | 1 |
Brooks, DJ; Chaudhuri, KR; Hu, MT; Jarosz, J; Yaguez, L | 1 |
Ishii, K; Ishiwata, K; Katayama, Y; Kitamura, S; Kobayashi, S; Mishina, M; Mitani, K; Ohyama, M; Senda, M; Yamazaki, M | 1 |
Choe, B; Juh, R; Kim, J; Moon, D; Suh, T | 1 |
Arai, H; Furukawa, Y; Hamaguchi, T; Ihara, Y; Ishida, C; Katayama, S; Kawakami, A; Kitamoto, T; Kohriyama, T; Kuji, I; Kuroda, S; Maruyama, M; Mitani, K; Mizusawa, H; Murayama, S; Nakamura, Y; Nishinaka, T; Noguchi, M; Sato, T; Shiga, Y; Suzuki, N; Udaka, F; Yamada, M; Yamamoto, T; Yamashita, M | 1 |
de Jong, BM; de Vries, JJ; Klein, RC; Leenders, KL | 1 |
Barnes, A; Dhawan, V; Eckert, T; Eidelberg, D; Feigin, AS; Frucht, S; Gordon, MF | 1 |
Brown, N; Eckert, T; Eidelberg, D; Feigin, A; Frucht, S; Lin, T; Ma, Y; Tang, C | 1 |
Ishii, K; Jamzad, M; Senda, M; Toyama, H | 1 |
Otsuka, M; Taniwaki, T | 1 |
Brooks, WS; Creasey, H; Fulham, MJ; Halliday, GM; Kwok, JB; Morris, JG; Schofield, PR; Stanford, PM; Storey, CE | 1 |
Foster, NL; Gilman, S; Heumann, ML; Johanns, J; Kuhl, DE; Little, R; Minoshima, S | 1 |
Degueldre, C; Destée, A; Franck, G; Garraux, G; Kreisler, A; Lemaire, C; Peigneux, P; Salmon, E | 1 |
Brooks, DJ; Ceravolo, R; de Yebenez, J; Lees, AJ; Piccini, P; Pramstaller, P; Turjanski, N | 1 |
Hirono, N; Hosaka, K; Ishii, K; Mori, E; Mori, T; Sakamoto, S; Sasaki, M | 1 |
Berent, S; D'Amato, C; Foster, NL; Gilman, S; Hicks, SP; Koeppe, RA; Sima, AA | 1 |
Grond, M; Heiss, WD; Herholz, K; Huber, M; Karbe, H; Kessler, J | 1 |
Heiss, WD; Herholz, K; Holthoff, V; Huber, M; Karbe, H; Wagner, R; Wienhard, K | 1 |
Kato, M | 1 |
Bol, A; Cogneau, M; De Volder, AG; Gillain, C; Goffinet, AM; Labar, D; Laterre, C; Michel, C; Rectem, D | 1 |
Berent, S; Brown, MB; Foster, NL; Gilman, S; Koeppe, RA; Morin, EM | 1 |
Hanson, WR; Metter, EJ | 1 |
2 review(s) available for fluorodeoxyglucose f18 and Supranuclear Palsy, Progressive
Article | Year |
---|---|
Clinical diagnosis of MM2-type sporadic Creutzfeldt-Jakob disease.
Topics: 14-3-3 Proteins; Age of Onset; Aged; Alzheimer Disease; Biomarkers; Blotting, Western; Cerebral Cortex; Cerebrospinal Fluid Proteins; Cerebrovascular Circulation; Creutzfeldt-Jakob Syndrome; Diagnosis, Differential; Diffusion Magnetic Resonance Imaging; Electroencephalography; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Phenotype; Positron-Emission Tomography; Prions; Supranuclear Palsy, Progressive; Thalamus; Tomography, Emission-Computed, Single-Photon | 2005 |
[Functional imaging for disorders of basal ganglia].
Topics: Basal Ganglia; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Huntington Disease; Multiple System Atrophy; Parkinson Disease; Radiopharmaceuticals; Supranuclear Palsy, Progressive; Tomography, Emission-Computed | 1999 |
2 trial(s) available for fluorodeoxyglucose f18 and Supranuclear Palsy, Progressive
Article | Year |
---|---|
Midbrain hypometabolism as early diagnostic sign for progressive supranuclear palsy.
Topics: Adult; Aged; Aged, 80 and over; Early Diagnosis; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Mesencephalon; Middle Aged; Radiopharmaceuticals; Regression Analysis; Supranuclear Palsy, Progressive; Tomography, Emission-Computed | 2004 |
Voxel-based comparison of regional cerebral glucose metabolism between PSP and corticobasal degeneration.
Topics: Brain; Caudate Nucleus; Dementia; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Frontal Lobe; Glucose; Humans; Male; Mesencephalon; Middle Aged; Neurodegenerative Diseases; Neuropsychological Tests; Occipital Lobe; Parietal Lobe; Parkinsonian Disorders; Predictive Value of Tests; Reference Values; Somatosensory Cortex; Supranuclear Palsy, Progressive; Tomography, Emission-Computed | 2002 |
53 other study(ies) available for fluorodeoxyglucose f18 and Supranuclear Palsy, Progressive
Article | Year |
---|---|
Abnormal metabolic covariance patterns associated with multiple system atrophy and progressive supranuclear palsy.
Topics: Fluorodeoxyglucose F18; Humans; Multiple System Atrophy; Parkinson Disease; Parkinsonian Disorders; Supranuclear Palsy, Progressive | 2022 |
Tau-PET and multimodal imaging in clinically atypical multiple system atrophy masquerading as progressive supranuclear palsy.
Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Levodopa; Magnetic Resonance Imaging; Multimodal Imaging; Multiple System Atrophy; Parkinson Disease; Parkinsonian Disorders; Supranuclear Palsy, Progressive | 2022 |
Brain FDG-PET correlates of saccadic disorders in early PSP.
Topics: Brain; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Retrospective Studies; Saccades; Supranuclear Palsy, Progressive | 2023 |
Automatic covariance pattern analysis outperforms visual reading of
Topics: Fluorodeoxyglucose F18; Humans; Movement Disorders; Positron-Emission Tomography; Retrospective Studies; Supranuclear Palsy, Progressive | 2023 |
The Added Value of Tau-PET in the Assessment of Progressive Supranuclear Palsy.
Topics: Aged; Aminopyridines; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Quinolines; Supranuclear Palsy, Progressive; tau Proteins | 2020 |
Differential diagnosis of parkinsonian syndromes: a comparison of clinical and automated - metabolic brain patterns' based approach.
Topics: Brain; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Parkinsonian Disorders; Supranuclear Palsy, Progressive | 2020 |
Clinical, MRI and 18F-FDG-PET/CT analysis of progressive supranuclear palsy.
Topics: Activities of Daily Living; Aged; Aged, 80 and over; Brain; Diagnosis, Differential; Early Diagnosis; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Supranuclear Palsy, Progressive | 2020 |
Neural correlates of naming errors across different neurodegenerative diseases: An FDG-PET study.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Aphasia, Primary Progressive; Connectome; Dementia; Female; Fluorodeoxyglucose F18; Frontotemporal Dementia; Humans; Language; Male; Neurodegenerative Diseases; Occipital Lobe; Pattern Recognition, Visual; Positron-Emission Tomography; Retrospective Studies; Semantics; Speech; Supranuclear Palsy, Progressive; Temporal Lobe | 2020 |
The evolution of parkinsonism in primary progressive apraxia of speech: A 6-year longitudinal study.
Topics: Aged; Apraxias; Brain; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Hypokinesia; Language Tests; Longitudinal Studies; Magnetic Resonance Imaging; Male; Middle Aged; Muscle Rigidity; Parkinsonian Disorders; Positron-Emission Tomography; Postural Balance; Radiopharmaceuticals; Speech Disorders; Supranuclear Palsy, Progressive; Tremor | 2020 |
The utility of FDG-PET in the differential diagnosis of Parkinsonism.
Topics: Adult; Aged; Aged, 80 and over; Brain; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multiple System Atrophy; Parkinson Disease; Parkinsonian Disorders; Positron-Emission Tomography; Radiopharmaceuticals; Supranuclear Palsy, Progressive | 2017 |
Reproducible network and regional topographies of abnormal glucose metabolism associated with progressive supranuclear palsy: Multivariate and univariate analyses in American and Chinese patient cohorts.
Topics: Aged; Brain; Brain Mapping; China; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Multiple System Atrophy; Nerve Net; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; Supranuclear Palsy, Progressive; United States | 2018 |
Validation of parkinsonian disease-related metabolic brain patterns.
Topics: Aged; Brain; Brain Mapping; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Multiple System Atrophy; Parkinsonian Disorders; Positron-Emission Tomography; Supranuclear Palsy, Progressive | 2013 |
FDG-PET in pathologically confirmed spontaneous 4R-tauopathy variants.
Topics: Age of Onset; Aged; Aged, 80 and over; Autopsy; Brain Chemistry; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neuroglia; Positron-Emission Tomography; Radiopharmaceuticals; Supranuclear Palsy, Progressive; Tauopathies | 2014 |
Neuronal correlates of clinical asymmetry in progressive supranuclear palsy.
Topics: Aged; Aged, 80 and over; Brain Mapping; Female; Fluorodeoxyglucose F18; Humans; Male; Neurons; Positron-Emission Tomography; Prognosis; Supranuclear Palsy, Progressive | 2014 |
Transcranial sonography and [18F]fluorodeoxyglucose positron emission tomography for the differential diagnosis of parkinsonism: a head-to-head comparison.
Topics: Aged; Brain; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multiple System Atrophy; Parkinsonian Disorders; Radionuclide Imaging; Sensitivity and Specificity; Supranuclear Palsy, Progressive; Ultrasonography, Doppler, Transcranial | 2014 |
Functional correlates of vertical gaze palsy and other ocular motor deficits in PSP: an FDG-PET study.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Ocular Motility Disorders; Positron-Emission Tomography; Radiopharmaceuticals; Supranuclear Palsy, Progressive | 2014 |
The evolution of primary progressive apraxia of speech.
Topics: Age of Onset; Aged; Brain; Cognition; Diffusion Tensor Imaging; Disease Progression; Educational Status; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Neuroimaging; Neurologic Examination; Neuropsychological Tests; Positron-Emission Tomography; Radiopharmaceuticals; Speech; Speech Disorders; Supranuclear Palsy, Progressive | 2014 |
A disease-specific metabolic brain network associated with corticobasal degeneration.
Topics: Aged; Aged, 80 and over; Basal Ganglia Diseases; Cerebral Cortex; Cerebrum; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Metabolic Networks and Pathways; Middle Aged; Multiple System Atrophy; Nerve Net; Neurodegenerative Diseases; Parkinsonian Disorders; Positron-Emission Tomography; Reproducibility of Results; Sensitivity and Specificity; Supranuclear Palsy, Progressive | 2014 |
Palatal tremor in progressive supranuclear palsy: a case report.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Mesencephalon; Palate; Positron-Emission Tomography; Supranuclear Palsy, Progressive; Tremor | 2015 |
PET-CT imaging in a patient with progressive supranuclear palsy.
Topics: Aged; Brain; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Parkinsonian Disorders; Positron-Emission Tomography; Radiopharmaceuticals; Supranuclear Palsy, Progressive | 2015 |
18F-FDG PET Is an Early Predictor of Overall Survival in Suspected Atypical Parkinsonism.
Topics: Aged; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Lewy Body Disease; Male; Middle Aged; Movement Disorders; Parkinsonian Disorders; Positron-Emission Tomography; Predictive Value of Tests; Proportional Hazards Models; Radiopharmaceuticals; Supranuclear Palsy, Progressive; Survival Analysis | 2015 |
Does Microglial Activation Influence Hippocampal Volume and Neuronal Function in Alzheimer's Disease and Parkinson's Disease Dementia?
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Antineoplastic Agents; Brain Mapping; Cognition; Female; Fluorodeoxyglucose F18; Hippocampus; Humans; Isoquinolines; Magnetic Resonance Imaging; Male; Microglia; Middle Aged; Neurons; Neuropsychological Tests; Parkinson Disease; Positron-Emission Tomography; Psychiatric Status Rating Scales; Supranuclear Palsy, Progressive | 2016 |
Plasma Screening for Progranulin Mutations in Patients with Progressive Supranuclear Palsy and Corticobasal Syndromes.
Topics: Aged; Aged, 80 and over; Brain Diseases; DNA-Binding Proteins; Female; Fluorodeoxyglucose F18; Genotype; Humans; Intercellular Signaling Peptides and Proteins; Male; Middle Aged; Mutation; Positron-Emission Tomography; Progranulins; Supranuclear Palsy, Progressive | 2016 |
An autopsy confirmed case of progressive supranuclear palsy with predominant cerebellar ataxia.
Topics: Autopsy; Brain; Cerebellar Ataxia; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Supranuclear Palsy, Progressive | 2016 |
Tau neuropathology correlates with FDG-PET, but not AV-1451-PET, in progressive supranuclear palsy.
Topics: Aged; Brain; Carbolines; Fatal Outcome; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Radiopharmaceuticals; Supranuclear Palsy, Progressive; tau Proteins | 2017 |
18F-AV-1451 positron emission tomography in Alzheimer's disease and progressive supranuclear palsy.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Autopsy; Autoradiography; Brain; Carbolines; Case-Control Studies; Cognition Disorders; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Protein Binding; Psychiatric Status Rating Scales; Supranuclear Palsy, Progressive; tau Proteins | 2017 |
Functional brain imaging in pure akinesia with gait freezing: [18F] FDG PET and [18F] FP-CIT PET analyses.
Topics: Aged; Aged, 80 and over; Basal Ganglia Diseases; Brain; Carbon Radioisotopes; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gait Disorders, Neurologic; Glucose; Humans; Hypokinesia; Iodine Radioisotopes; Magnetic Resonance Imaging; Male; Mesencephalon; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; Supranuclear Palsy, Progressive; Tropanes | 2009 |
Teaching NeuroImages: FDG-PET in progressive supranuclear palsy.
Topics: Accidental Falls; Aged; Atrophy; Biomarkers; Brain; Deglutition Disorders; Diagnosis, Differential; Fluorodeoxyglucose F18; Frontal Lobe; Humans; Male; Mesencephalon; Ocular Motility Disorders; Personality Disorders; Positron-Emission Tomography; Predictive Value of Tests; Supranuclear Palsy, Progressive | 2010 |
Glucose metabolism in progressive nonfluent aphasia with and without parkinsonism.
Topics: Aged; Basal Ganglia Diseases; Female; Fluorodeoxyglucose F18; Glucose; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Primary Progressive Nonfluent Aphasia; Radiopharmaceuticals; Retrospective Studies; Supranuclear Palsy, Progressive | 2010 |
Postural imbalance and falls in PSP correlate with functional pathology of the thalamus.
Topics: Accidental Falls; Aged; Brain Mapping; Disability Evaluation; Eye; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Oxygen; Positron-Emission Tomography; Postural Balance; Rest; Statistics as Topic; Supranuclear Palsy, Progressive; Thalamus | 2011 |
Localizing imbalance in progressive supranuclear palsy: is the thalamus the "fall guy"?
Topics: Diagnostic Imaging; Fluorodeoxyglucose F18; Gait Disorders, Neurologic; Humans; Radionuclide Imaging; Supranuclear Palsy, Progressive; Thalamus | 2011 |
18F-FDG PET study on the idiopathic Parkinson's disease from several parkinsonian-plus syndromes.
Topics: Aged; Aged, 80 and over; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lewy Body Disease; Male; Middle Aged; Multiple System Atrophy; Parkinson Disease; Positron-Emission Tomography; Supranuclear Palsy, Progressive; Syndrome | 2012 |
Fluorodeoxyglucose positron emission tomography in Richardson’s syndrome and progressive supranuclear palsy-parkinsonism.
Topics: Aged; Brain; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Putamen; ROC Curve; Severity of Illness Index; Supranuclear Palsy, Progressive; Thalamus | 2012 |
[¹⁸F]FDG-PET is superior to [¹²³I]IBZM-SPECT for the differential diagnosis of parkinsonism.
Topics: Aged; Diagnosis, Differential; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Iodobenzenes; Lewy Body Disease; Male; Middle Aged; Multiple System Atrophy; Neurodegenerative Diseases; Parkinson Disease; Parkinsonian Disorders; Positron-Emission Tomography; Supranuclear Palsy, Progressive; Tomography, Emission-Computed, Single-Photon | 2012 |
[A study on the cerebral glucose metabolism in progressive supranuclear palsy].
Topics: Aged; Brain; Case-Control Studies; Dementia; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Supranuclear Palsy, Progressive | 2012 |
Functional disturbance of the locomotor network in progressive supranuclear palsy.
Topics: Aged; Brain; Brain Mapping; Case-Control Studies; Female; Fluorodeoxyglucose F18; Humans; Locomotion; Male; Middle Aged; Neural Pathways; Positron-Emission Tomography; Prospective Studies; Rest; Severity of Illness Index; Supranuclear Palsy, Progressive | 2013 |
An imaging study of parkinsonism among African-Caribbean and Indian London communities.
Topics: Adult; Aged; Black People; Brain; Cerebral Cortex; Corpus Striatum; Cross-Cultural Comparison; Diagnosis, Differential; Energy Metabolism; Female; Fluorodeoxyglucose F18; Humans; India; Lewy Body Disease; London; Magnetic Resonance Imaging; Male; Middle Aged; Multiple System Atrophy; Neuropsychological Tests; Parkinsonian Disorders; Radiography; Radionuclide Imaging; Supranuclear Palsy, Progressive; West Indies; White People | 2002 |
Different metabolic patterns analysis of Parkinsonism on the 18F-FDG PET.
Topics: Aged; Brain; Case-Control Studies; Caudate Nucleus; Cerebellum; Female; Fluorodeoxyglucose F18; Glucose; Gyrus Cinguli; Humans; Male; Mesencephalon; Middle Aged; Multiple System Atrophy; Neocortex; Parkinson Disease; Parkinsonian Disorders; Pons; Positron-Emission Tomography; Putamen; Radiopharmaceuticals; Retrospective Studies; Supranuclear Palsy, Progressive; Thalamus | 2004 |
Direct comparison between regional cerebral metabolism in progressive supranuclear palsy and Parkinson's disease.
Topics: Aged; Blood Glucose; Brain Mapping; Cerebral Cortex; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Regional Blood Flow; Supranuclear Palsy, Progressive | 2005 |
FDG PET in the differential diagnosis of parkinsonian disorders.
Topics: Aged; Aging; Brain; Brain Mapping; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Multiple System Atrophy; Nerve Degeneration; Parkinsonian Disorders; Positron-Emission Tomography; Radiopharmaceuticals; Supranuclear Palsy, Progressive | 2005 |
Abnormal metabolic networks in atypical parkinsonism.
Topics: Aged; Brain Stem; Cerebellum; Cohort Studies; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Frontal Lobe; Humans; Male; Middle Aged; Multiple System Atrophy; Nerve Net; Parkinsonian Disorders; Positron-Emission Tomography; Putamen; Reference Values; Reproducibility of Results; Supranuclear Palsy, Progressive | 2008 |
A human friendly reporting and database system for brain PET analysis.
Topics: Alzheimer Disease; Brain; Brain Diseases; Computer Graphics; Computer Systems; Data Interpretation, Statistical; Databases, Factual; Deoxyglucose; Epilepsy, Temporal Lobe; Evaluation Studies as Topic; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Supranuclear Palsy, Progressive; Tissue Distribution; Tomography, Emission-Computed | 1996 |
Progressive supranuclear palsy pathology caused by a novel silent mutation in exon 10 of the tau gene: expansion of the disease phenotype caused by tau gene mutations.
Topics: Aged; Aged, 80 and over; Atrophy; Basal Ganglia; Base Sequence; Brain; Child; Chromosomes, Human, Pair 17; Dinucleotide Repeats; Exons; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Mutation; Neurofibrillary Tangles; Pedigree; Phenotype; Polymorphism, Genetic; Radiopharmaceuticals; Supranuclear Palsy, Progressive; tau Proteins; Tomography, Emission-Computed | 2000 |
PET measures of benzodiazepine receptors in progressive supranuclear palsy.
Topics: Aged; Aged, 80 and over; Blood Glucose; Brain; Brain Mapping; Female; Flumazenil; Fluorodeoxyglucose F18; GABA Modulators; Gyrus Cinguli; Humans; Male; Middle Aged; Predictive Value of Tests; Receptors, GABA-A; Reference Values; Supranuclear Palsy, Progressive; Tomography, Emission-Computed | 2000 |
Voxel-based distribution of metabolic impairment in corticobasal degeneration.
Topics: Adult; Aged; Aged, 80 and over; Basal Ganglia Diseases; Blood Glucose; Brain; Brain Diseases, Metabolic; Case-Control Studies; Energy Metabolism; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Nerve Net; Neurodegenerative Diseases; Radiopharmaceuticals; Supranuclear Palsy, Progressive; Tomography, Emission-Computed | 2000 |
Familial progressive supranuclear palsy: detection of subclinical cases using 18F-dopa and 18fluorodeoxyglucose positron emission tomography.
Topics: Adult; Aged; Caudate Nucleus; Dihydroxyphenylalanine; Dopamine Agents; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Genetic Predisposition to Disease; Humans; Male; Middle Aged; Pedigree; Putamen; Radiopharmaceuticals; Supranuclear Palsy, Progressive; Tomography, Emission-Computed | 2001 |
Progressive subcortical gliosis and progressive supranuclear palsy can have similar clinical and PET abnormalities.
Topics: Blood Glucose; Brain; Deoxyglucose; Diagnosis, Differential; Energy Metabolism; Fluorodeoxyglucose F18; Gliosis; Humans; Neurofibrillary Tangles; Neurologic Examination; Neuropsychological Tests; Supranuclear Palsy, Progressive; Tomography, Emission-Computed | 1992 |
Subcortical damage and cortical dysfunction in progressive supranuclear palsy demonstrated by positron emission tomography.
Topics: Aged; Basal Ganglia; Cerebral Cortex; Deoxyglucose; Energy Metabolism; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glycolysis; Humans; Male; Mesencephalon; Middle Aged; Supranuclear Palsy, Progressive; Tomography, Emission-Computed | 1992 |
Positron emission tomography in degenerative disorders of the dopaminergic system.
Topics: Adult; Aged; Alzheimer Disease; Basal Ganglia; Brain; Brain Stem; Deoxyglucose; Dihydroxyphenylalanine; Dopamine; Female; Fluorodeoxyglucose F18; Frontal Lobe; Glucose; Humans; Male; Middle Aged; Parietal Lobe; Parkinson Disease; Supranuclear Palsy, Progressive; Tomography, Emission-Computed | 1992 |
[Positron emission tomography and basal ganglia functions].
Topics: Animals; Basal Ganglia; Basal Ganglia Diseases; Corpus Striatum; Deoxyglucose; Dopamine; Energy Metabolism; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Macaca mulatta; Mice; Parkinson Disease; Rats; Supranuclear Palsy, Progressive; Tomography, Emission-Computed | 1990 |
Positron tomography demonstrates frontal lobe hypometabolism in progressive supranuclear palsy.
Topics: Aged; Autoradiography; Blood Glucose; Brain Mapping; Deoxyglucose; Dominance, Cerebral; Fluorodeoxyglucose F18; Frontal Lobe; Humans; Neuropsychological Tests; Supranuclear Palsy, Progressive; Tomography, Emission-Computed | 1989 |
Cerebral hypometabolism in progressive supranuclear palsy studied with positron emission tomography.
Topics: Aged; Brain; Cerebral Cortex; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Functional Laterality; Humans; Male; Organ Specificity; Reference Values; Supranuclear Palsy, Progressive; Tomography, Emission-Computed | 1988 |
Clinical and acoustical variability in hypokinetic dysarthria.
Topics: Aged; Deoxyglucose; Dysarthria; Fluorine; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Parkinson Disease, Secondary; Phonation; Radioisotopes; Speech; Speech Acoustics; Speech Disorders; Supranuclear Palsy, Progressive; Tomography, Emission-Computed | 1986 |